{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:32:09Z","timestamp":1782516729991,"version":"3.54.5"},"reference-count":93,"publisher":"Bentham Science Publishers Ltd.","issue":"38","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2021,10,25]]},"abstract":"<jats:sec>\n<jats:title>Background and Objective:<\/jats:title>\n<jats:p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a\nhighly pathogenic virus, is responsible for a respiratory disease termed coronavirus disease 2019 (COVID-19).\nSARS-CoV-2 genome encodes various structural and non-structural proteins, which are necessary for viral entry\nand replication. Among these proteins, papain-like protease (PLpro), 3C-like protease (3CLpro), RNAdependent\nRNA polymerase (RdRp), helicase, serine protease, and spike protein are potential targets of herbal\nremedies and phytocompounds for inhibition of viral infection and replication. There is, at present, no confirmed\ncure for the COVID-19. Various plants and their components have been introduced against SARS-CoV-2.\nA number of review articles have also been published on them. This article is focused on the mechanistic aspects\nof these plants and their derivatives on SARS-CoV-2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The material in this review article was prepared from significant scientific databases, including Web\nof Science, PubMed, Science Direct, Scopus and Google Scholar.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Different medicinal plants and their phytocompounds interact with important structural and nonstructural\nof SARS-CoV-2 proteins. Natural compounds form strong bonds with the active site of SARS-CoV-2\nprotease and make large conformational changes. These phytochemicals are potential inhibitors of structural\nand non-structural SARS-CoV-2 proteins such as Spike protein, PLpro, and 3CLpro. Some important anti-\nSARS-CoV-2 actions of medicinal plants and their metabolites are: inhibition of the virus replication or entry,\nblocking the angiotensin-converting enzyme 2 (ACE-2) receptor and \u201cTransmembrane protease, serine 2\n(TMPRSS2), regulation of inflammatory mediators, inhibition of endothelial activation, toll-like receptors\n(TLRs) and activation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2). Some of these important\nnatural immune boosters that are helpful for the prevention and cure of various symptoms related to COVID-19\ninclude Allium sativum, Nigella sativa, Glycyrrhiza glabra Zingiber officinalis, Ocimum sanctum, Withania\nsomnifera, Tinospora cordifolia, and Scutellaria baicalensis. Also, Kaempferol, Quercetin, Baicalin, Scutellarin,\nGlycyrrhizin, Curcumin, Apigenin, Ursolic acid, and Chloroquine are the best candidates for treating the\nsymptoms associated with SARS-CoV-2 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Medicinal plants and\/or their bioactive compounds with inhibitory effects against SARS-CoV-2 support\nthe human immune system and help in fighting against COVID-19 and rejuvenating the immune system.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612827666210705160130","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:03:46Z","timestamp":1625562226000},"page":"3996-4007","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0668-4493","authenticated-orcid":true,"given":"Khojasteh","family":"Malekmohammad","sequence":"first","affiliation":[{"name":"Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-1141","authenticated-orcid":true,"given":"Mahmoud","family":"Rafieian-Kopaei","sequence":"additional","affiliation":[{"name":"Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"Su S.","year":"2016","unstructured":"Su S.; Wong G.; Shi W.; Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016,24(6),490-502","journal-title":"Trends Microbiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"Schoeman D.","year":"2019","unstructured":"Schoeman D.; Fielding B.C.; Coronavirus envelope protein: Current knowledge. Virol J 2019,16(1),69-91","journal-title":"Virol J"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","volume":"73","author":"Fung T.S.","year":"2019","unstructured":"Fung T.S.; Liu D.X.; Human coronavirus: Host-pathogen interaction. Annu Rev Microbiol 2019,73,529-557","journal-title":"Annu Rev Microbiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Liu Q.; Guo D.; Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020,92(4),418-423","journal-title":"J Med Virol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","volume":"323","author":"Paules C.I.","year":"2020","unstructured":"Paules C.I.; Marston H.D.; Fauci A.S.; Coronavirus infections-more than just the common cold. JAMA 2020,323(8),707-708","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"Chan J.F.","year":"2015","unstructured":"Chan J.F.; Lau S.K.; To K.K.; Cheng V.C.; Woo P.C.; Yuen K.Y.; Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015,28(2),465-522","journal-title":"Clin Microbiol Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"Chen N.","year":"2020","unstructured":"Chen N.; Zhou M.; Dong X.; Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020,395(10223),507-513","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","volume":"28","author":"Seah I.","year":"2020","unstructured":"Seah I.; Agrawal R.; Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 2020,28(3),391-395","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fmicb.2019.00569","volume":"10","author":"Skariyachan S.","year":"2019","unstructured":"Skariyachan S.; Challapilli S.B.; Packirisamy S.; Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for middleeast respiratory syndrome coronavirus infections. Front Microbiol 2019,10,569","journal-title":"Front Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med 2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101575","volume":"35","author":"Bonilla-Aldana D.K.","year":"2020","unstructured":"Bonilla-Aldana D.K.; Holguin-Rivera Y.; Cortes-Bonilla I.; Coronavirus infections reported by ProMED, february 2000\u2013january 2020. Travel Med Infect Dis 2020,35","journal-title":"Travel Med Infect Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12519-020-00343-7","volume":"16","author":"Shen K.","year":"2020","unstructured":"Shen K.; Yang Y.; Wang T.; Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: Experts\u2019 consensus statement. World J Pediatr 2020,16(3),223-231","journal-title":"World J Pediatr"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"Chan J.F.","year":"2020","unstructured":"Chan J.F.; Yuan S.; Kok K.H.; A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020,395(10223),514-523","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhin.2020.01.022","volume":"104","author":"Kampf G.","year":"2020","unstructured":"Kampf G.; Todt D.; Pfaender S.; Steinmann E.; Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020,104(3),246-251","journal-title":"J Hosp Infect"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7276","volume":"12","author":"Ramphul K.","year":"2020","unstructured":"Ramphul K.; Mejias S.G.; Coronavirus disease: A review of a new threat to public health. Cureus 2020,12(3)","journal-title":"Cureus"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/emp2.12034","volume":"1","author":"Yee J.","year":"2020","unstructured":"Yee J.; Unger L.; Zadravecz F.; Novel coronavirus 2019 (COVID-19): Emergence and implications for emergency care. J Am Coll Emerg Physicians Open 2020,1,63-69","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40249-020-00646-x","volume":"9","author":"Adhikari S.P.","year":"2020","unstructured":"Adhikari S.P.; Meng S.; Wu Y.J.; Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty 2020,9(1),29","journal-title":"Infect Dis Poverty"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.20944\/ preprints202002.0220.v1","volume":"15","author":"Tian S.","year":"2020","unstructured":"Tian S.; Hu W.; Niu L.; Lin H.; Xu H.; Xiao S.Y.; Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020,15(5),700-704","journal-title":"J Thorac Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"Letko M.","year":"2020","unstructured":"Letko M.; Marzi A.; Munster V.; Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020,5(4),562-569","journal-title":"Nat Microbiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"Lu R.","year":"2020","unstructured":"Lu R.; Zhao X.; Li J.; Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020,395(10224),565-574","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"Wu F.","year":"2020","unstructured":"Wu F.; Zhao S.; Yu B.; A new coronavirus associated with human respiratory disease in China. Nature 2020,579(7798),265-269","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pathogens9020148","volume":"9","author":"Shanmugaraj B.","year":"2020","unstructured":"Shanmugaraj B.; Malla A.; Phoolcharoen W.; Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development. Pathogens 2020,9(2),148-158","journal-title":"Pathogens"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Wan Y.","year":"2020","unstructured":"Wan Y.; Shang J.; Graham R.; Baric R.S.; Li F.; Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020,94(7),1-9","journal-title":"J Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X.L.; Wang X.G.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.3390\/v11010059","volume":"11","author":"Song Z.","year":"2019","unstructured":"Song Z.; Xu Y.; Bao L.; From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 2019,11(1),E59-E87","journal-title":"Viruses"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1835716","volume":"1-4","author":"Mosquera-Yuqui F.","year":"2020","unstructured":"Mosquera-Yuqui F.; Lopez-Guerra N.; Moncayo-Palacio E.A.; Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: Molecular docking and molecular dynamics simulations. J Biomol Struct Dyn 2020,1-4,1-14","journal-title":"J Biomol Struct Dyn"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/molecules26020448","volume":"26","author":"Vougogiannopoulou K.","year":"2021","unstructured":"Vougogiannopoulou K.; Corona A.; Tramontano E.; Alexis M.N.; Skaltsounis A.L.; Natural and nature-derived products targeting human coronaviruses. Molecules 2021,26(2),448","journal-title":"Molecules"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ ptr.7041","volume":"\u2022","author":"Sisakht M.","year":"2021","unstructured":"Sisakht M.; Mahmoodzadeh A.; Darabian M.; Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study. Phytother Res 2021,\u2022,1-13","journal-title":"Phytother Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11010-021-04084-7","volume":"476","author":"Patel B.","year":"2021","unstructured":"Patel B.; Sharma S.; Nair N.; Majeed J.; Goyal R.K.; Dhobi M.; Therapeutic opportunities of edible antiviral plants for COVID-19. Mol Cell Biochem 2021,476(6),2345-2364","journal-title":"Mol Cell Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6237160","volume":"2020","author":"Kousar K.","year":"2020","unstructured":"Kousar K.; Majeed A.; Yasmin F.; Hussain W.; Rasool N.; Phytochemicals from selective plants have promising potential against sars-cov-2: Investigation and corroboration through molecular docking, md simulations, and quantum computations. BioMed Res Int 2020,2020","journal-title":"BioMed Res Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/ph13100277","volume":"13","author":"Petushkova A.I.","year":"2020","unstructured":"Petushkova A.I.; Zamyatnin A.A.; Papain-like proteases as coronaviral drug targets: Current inhibitors, opportunities, and limitations. Pharmaceuticals (Basel) 2020,13(10),277","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ptr.6873","volume":"\u2022","author":"Boozari M.","year":"2020","unstructured":"Boozari M.; Hosseinzadeh H.; Natural products for COVID\u201019 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res 2020,\u2022,1-13","journal-title":"Phytother Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26030727","volume":"26","author":"Sytar O.","year":"2021","unstructured":"Sytar O.; Brestic M.; Hajihashemi S.; COVID-19 prophylaxis efforts based on natural antiviral plant extracts and their compounds. Molecules 2021,26(3),1-19","journal-title":"Molecules"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21276\/ap.2020.9.2.3","volume":"9","author":"Bellik Y.","year":"2020","unstructured":"Bellik Y.; Bachir-Bey M.; Fatmi W.; Micronutrients and phytochemicals against COVID-19: Mechanism and molecular targets. Ann Phytomed 2020,9,15-29","journal-title":"Ann Phytomed"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/medicina57020169","volume":"57","author":"Ali S.G.","year":"2021","unstructured":"Ali S.G.; Ansari M.A.; Alzohairy M.A.; Natural products and nutrients against different viral diseases: Prospects in prevention and treatment of sars-cov-2. Medicina (B Aires) 2021,57(2),169","journal-title":"Medicina (B Aires)"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40121-021-00400-2","volume":"10","author":"Xu H.","year":"2021","unstructured":"Xu H.; Liu B.; Xiao Z.; Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect Dis Ther 2021,10(1),483-494","journal-title":"Infect Dis Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/molecules26061775","volume":"26","author":"Anand A.V.","year":"2021","unstructured":"Anand A.V.; Balamuralikrishnan B.; Kaviya M.; Medicinal plants, phytochemicals, and herbs to combat viral pathogens including sars-cov-2. Molecules 2021,26(6),1775","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/molecules26061754","volume":"26","author":"Hafez Ghoran S.","year":"2021","unstructured":"Hafez Ghoran S.; El-Shazly M.; Sekeroglu N.; Kijjoa A.; Natural products from medicinal plants with anti-human coronavirus activities. Molecules 2021,26(6),1754","journal-title":"Molecules"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2020.101890","volume":"31","author":"Khan T.","year":"2021","unstructured":"Khan T.; Khan M.A.; Mashwani Z.U.; Ullah N.; Nadhman A.; Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatal Agric Biotechnol 2021,31","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.197989","volume":"284","author":"Mani J.S.","year":"2020","unstructured":"Mani J.S.; Johnson J.B.; Steel J.C.; Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res 2020,284","journal-title":"Virus Res"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.611408","volume":"12","author":"Lim X.Y.","year":"2021","unstructured":"Lim X.Y.; Teh B.P.; Tan T.Y.C.; Medicinal plants in covid-19: Potential and limitations. Front Pharmacol 2021,12","journal-title":"Front Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021579118","volume":"118","author":"Jan J.T.","year":"2021","unstructured":"Jan J.T.; Cheng T.R.; Juang Y.P.; Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc Natl Acad Sci USA 2021,118(5)","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s40203-020-00073-8","volume":"9","author":"Alrasheid A.A.","year":"2021","unstructured":"Alrasheid A.A.; Babiker M.Y.; Awad T.A.; Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis. In Silico Pharmacol 2021,9(1),10","journal-title":"In Silico Pharmacol"},{"key":"ref=45","first-page":"1","volume":"\u2022","author":"Aanouz I.","year":"2020","unstructured":"Aanouz I.; Belhassan A.; El-Khatabi K.; Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn 2020,\u2022,1-9","journal-title":"J Biomol Struct Dyn"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/jmv.26814","volume":"93","author":"Anirudhan V.","year":"2021","unstructured":"Anirudhan V.; Lee H.; Cheng H.; Cooper L.; Rong L.; Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19. J Med Virol 2021,93(5),2722-2734","journal-title":"J Med Virol"},{"key":"ref=47","first-page":"23","volume":"2","author":"Mazraedoost S.","year":"2021","unstructured":"Mazraedoost S.; Behbudi G.; Mousavi S.M.; Covid-19 treatment by plant compounds. AANBT 2021,2,23-33","journal-title":"AANBT"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/22221751.2020.1745095","volume":"9","author":"Loeffelholz M.J.","year":"2020","unstructured":"Loeffelholz M.J.; Tang Y.W.; Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect 2020,9(1),747-756","journal-title":"Emerg Microbes Infect"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2020.06.045","volume":"510","author":"Li C.","year":"2020","unstructured":"Li C.; Zhao C.; Bao J.; Tang B.; Wang Y.; Gu B.; Laboratory diagnosis of coronavirus disease-2019 (COVID-19). Clin Chim Acta 2020,510,35-46","journal-title":"Clin Chim Acta"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"Singhal T.","year":"2020","unstructured":"Singhal T.; A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020,87(4),281-286","journal-title":"Indian J Pediatr"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","volume":"25","author":"Corman V.M.","year":"2020","unstructured":"Corman V.M.; Landt O.; Kaiser M.; Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020,25(3)","journal-title":"Euro Surveill"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA 2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"Xu X.W.","year":"2020","unstructured":"Xu X.W.; Wu X.X.; Jiang X.G.; Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ 2020,368,m606","journal-title":"BMJ"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/jmv.25727","volume":"92","author":"Li Z.","year":"2020","unstructured":"Li Z.; Yi Y.; Luo X.; Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020,92(9),1518-1524","journal-title":"J Med Virol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e00461","DOI":"10.1128\/JCM.00461-20","volume":"58","author":"Liu W.","year":"2020","unstructured":"Liu W.; Liu L.; Kou G.; Evaluation of nucleocapsid and spike protein-based elisas for detecting antibodies against sars-cov-2. J Clin Microbiol 2020,58,e00461-e20","journal-title":"J Clin Microbiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","volume":"66","author":"Chu D.K.W.","year":"2020","unstructured":"Chu D.K.W.; Pan Y.; Cheng S.M.S.; Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 2020,66(4),549-555","journal-title":"Clin Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/jcm9030623","volume":"9","author":"Pang J.","year":"2020","unstructured":"Pang J.; Wang M.X.; Ang I.Y.H.; Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med 2020,9(3),623-656","journal-title":"J Clin Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/mi11030306","volume":"11","author":"Nguyen T.","year":"2020","unstructured":"Nguyen T.; Duong Bang D.; Wolff A.; 2019 novel coronavirus disease (COVID-19): Paving the road for rapid detection and point-of-care diagnostics. Micromachines (Basel) 2020,11(3),306-313","journal-title":"Micromachines (Basel)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","volume":"9","author":"Zhang W.","year":"2020","unstructured":"Zhang W.; Du R.H.; Li B.; Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg Microbes Infect 2020,9(1),386-389","journal-title":"Emerg Microbes Infect"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1007\/s00330-020-06731-x","volume":"30","author":"Pan Y.","year":"2020","unstructured":"Pan Y.; Guan H.; Zhou S.; Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): A study of 63 patients in Wuhan, China. Eur Radiol 2020,30(6),3306-3309","journal-title":"Eur Radiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/biom9110696","volume":"9","author":"Kim D.E.","year":"2019","unstructured":"Kim D.E.; Min J.S.; Jang M.S.; Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus oc43 infection of mrc-5 human lung cells. Biomolecules 2019,9(11),696-712","journal-title":"Biomolecules"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/jm070295s","volume":"50","author":"Wen C.C.","year":"2007","unstructured":"Wen C.C.; Kuo Y.H.; Jan J.T.; Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 2007,50(17),4087-4095","journal-title":"J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","volume":"18","author":"Zhang D.H.","year":"2020","unstructured":"Zhang D.H.; Wu K.L.; Zhang X.; Deng S.Q.; Peng B.; \n                        In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020,18(2),152-158","journal-title":"J Integr Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"Tahir Ul Qamar M.","year":"2020","unstructured":"Tahir Ul Qamar M.; Alqahtani S.M.; Alamri M.A.; Chen L.L.; Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 2020,10(4),313-319","journal-title":"J Pharm Anal"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","volume":"26","author":"Luo H.","year":"2020","unstructured":"Luo H.; Tang Q.L.; Shang Y.X.; Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med 2020,26(4),243-250","journal-title":"Chin J Integr Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.7150\/ijbs.45538","volume":"16","author":"Yang Y.","year":"2020","unstructured":"Yang Y.; Islam M.S.; Wang J.; Li Y.; Chen X.; Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int J Biol Sci 2020,16(10),1708-1717","journal-title":"Int J Biol Sci"},{"key":"ref=67","first-page":"2167","volume":"9","author":"Srivastava A.K.","year":"2020","unstructured":"Srivastava A.K.; Chaurasia J.P.; Khan R.; Role of medicinal plants of traditional use in recuperating devastating covid-19 situation. Med Aromat Plants 2020,9,2167-0412","journal-title":"Med Aromat Plants"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"27961","DOI":"10.1039\/D0RA05126H","volume":"10","author":"Shawky E.","year":"2020","unstructured":"Shawky E.; Nada A.A.; Ibrahim R.S.; Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: Identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Advances 2020,10,27961-27983","journal-title":"RSC Advances"},{"key":"ref=69","author":"Mohammadi N.","year":"2020","unstructured":"Mohammadi N.; Shaghaghi N; Inhibitory effect of eight secondary metabolites from conventional medicinal plants on covid-19 virus protease by molecular docking analysis ChemRxiv 2020","journal-title":"ChemRxiv"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.571434","volume":"11","author":"Bahramsoltani R.","year":"2020","unstructured":"Bahramsoltani R.; Rahimi R.; An evaluation of traditional persian medicine for the management of sars-cov-2. Front Pharmacol 2020,11","journal-title":"Front Pharmacol"},{"key":"ref=71","author":"Chen H","year":"2020","unstructured":"Chen H; Du Q;  2020"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","volume":"10","author":"Xian Y.","year":"2020","unstructured":"Xian Y.; Zhang J.; Bian Z.; Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharm Sin B 2020,10(7),1163-1174","journal-title":"Acta Pharm Sin B"},{"key":"ref=73","author":"Srivastava AK","year":"2020","unstructured":"Srivastava AK; Kumar A; Misra N;  2020"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1774419","volume":"\u2022","author":"Borkotoky S.","year":"2020","unstructured":"Borkotoky S.; Banerjee M.; A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). J Biomol Struct Dyn 2020,\u2022,1-17","journal-title":"J Biomol Struct Dyn"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1021\/acs.jcim.0c00491","volume":"60","author":"Ngo S.T.","year":"2020","unstructured":"Ngo S.T.; Quynh Anh Pham N.; Thi Le L.; Computational determination of potential inhibitors of SARS-CoV-2 main protease.  J Chem Inf Model 2020,60,5771-5780","journal-title":"J Chem Inf Model"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ptr.6893","volume":"\u2022","author":"Adhikari B.","year":"2020","unstructured":"Adhikari B.; Marasini B.P.; Rayamajhee B.; Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID\u201019: A review. Phytother Res 2020,\u2022,1-15","journal-title":"Phytother Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1810778","volume":"1-4","author":"Shree P.","year":"2020","unstructured":"Shree P.; Mishra P.; Selvaraj C.; Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study. J Biomol Struct Dyn 2020,1-4,1-14","journal-title":"J Biomol Struct Dyn"},{"key":"ref=78","author":"Khaerunnisa S","year":"2020","unstructured":"Khaerunnisa S; Kurniawan H; Awaluddin R;  2020"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1842246","volume":"\u2022","author":"Mondal P.","year":"2020","unstructured":"Mondal P.; Natesh J.; Abdul Salam A.A.; Thiyagarajan S.; Meeran S.M.; Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: Computational investigation. J Biomol Struct Dyn 2020,\u2022,1-18","journal-title":"J Biomol Struct Dyn"},{"key":"ref=80","author":"Liu X.","year":"2019","unstructured":"Liu X.; Zhang B.; Jin Z.;  The crytal structure of 2019-ncov main protease in complex with an inhibitor N3 2019","journal-title":"The crytal structure of 2019-ncov main protease in complex with an inhibitor N3"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3389\/fphar.2020.01189","volume":"11","author":"Benarba B.","year":"2020","unstructured":"Benarba B.; Pandiella A.; Medicinal plants as sources of active molecules against COVID-19. Front Pharmacol 2020,11,1189","journal-title":"Front Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/plants9060800","volume":"9","author":"Boukhatem M.N.","year":"2020","unstructured":"Boukhatem M.N.; Setzer W.N.; Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: Future perspectives. Plants 2020,9(6),800","journal-title":"Plants"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107618","volume":"214","author":"Bailly C.","year":"2020","unstructured":"Bailly C.; Vergoten G.; Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Ther 2020,214","journal-title":"Pharmacol Ther"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198169","volume":"290","author":"Khare P.","year":"2020","unstructured":"Khare P.; Sahu U.; Pandey S.C.; Samant M.; Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Virus Res 2020,290","journal-title":"Virus Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00299-020-02560-w","volume":"39","author":"Prasad A.","year":"2020","unstructured":"Prasad A.; Muthamilarasan M.; Prasad M.; Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Plant Cell Rep 2020,39(9),1109-1114","journal-title":"Plant Cell Rep"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jiph.2020.09.002","volume":"13","author":"Chidambaram S.K.","year":"2020","unstructured":"Chidambaram S.K.; Ali D.; Alarifi S.; Radhakrishnan S.; Akbar I.; \n                        In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2. J Infect Public Health 2020,13(11),1671-1677","journal-title":"J Infect Public Health"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1808075","volume":"\u2022","author":"Maurya A.K.","year":"2020","unstructured":"Maurya A.K.; Mishra N.; \n                        in silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10\/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2. J Biomol Struct Dyn 2020,\u2022,1-16","journal-title":"J Biomol Struct Dyn"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111430","volume":"138","author":"Liskova A.","year":"2021","unstructured":"Liskova A.; Samec M.; Koklesova L.; Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother 2021,138","journal-title":"Biomed Pharmacother"},{"key":"ref=89","first-page":"3422","volume":"24","author":"Balachandar V.","year":"2020","unstructured":"Balachandar V.; Mahalaxmi I.; Kaavya J.; COVID-19: Emerging protective measures. Eur Rev Med Pharmacol Sci 2020,24(6),3422-3425","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/molecules25040821","volume":"25","author":"Muchtaridi M.","year":"2020","unstructured":"Muchtaridi M.; Sugijanto M.; Mohd Gazzali A.; Wahab H.A.; Anti-neuraminidase bioactives from Manggis Hutan (Garcinia celebica L.) leaves: Partial purification and molecular characterization. Molecules 2020,25(4),821","journal-title":"Molecules"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.561334","volume":"11","author":"Verma S.","year":"2020","unstructured":"Verma S.; Twilley D.; Esmear T.; Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19). Front Pharmacol 2020,11","journal-title":"Front Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113869","volume":"270","author":"Wang Z.","year":"2021","unstructured":"Wang Z.; Yang L.; Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021,270","journal-title":"J Ethnopharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.588467","volume":"11","author":"Majnooni M.B.","year":"2020","unstructured":"Majnooni M.B.; Fakhri S.; Shokoohinia Y.; Phytochemicals: Potential therapeutic interventions against coronavirus-associated lung injury. Front Pharmacol 2020,11","journal-title":"Front Pharmacol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/194477","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194477\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/194477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T06:31:35Z","timestamp":1635402695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194477\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":93,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2021,10,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612827666210705160130","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}